Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors.

Psycho-oncology
Errol J PhilipCarolyn A Heitzmann

Abstract

An estimated 30% of cancer patients are expected to experience clinically significant psychological distress during the treatment phase of their disease. Despite significant attention being directed to the mental health needs of individuals undergoing and completing treatment, there is less known about the mental health needs of survivors and the role of potential protective factors in survivorship, such as coping self-efficacy and social support. One hundred and twenty-four post-treatment cancer survivors (mean age = 62.23 years, women = 70%, average 9.3 years post-treatment) were asked to complete measures of physical symptoms, coping self-efficacy, social support, and depression as part of a national convenience sample of cancer patients and survivors. About 20% of participants possessed scores on the Center for Epidemiologic Studies-Depressed Mood Scale indicative of clinically relevant depression. Coping self-efficacy was not only a significant predictor of depression (43% Variance Accounted For); it also partially mediated the relationship between symptoms and depression. Social support accounted for limited variance and was not a significant predictor of depression in a model containing both social support and coping sel...Continue Reading

References

Sep 1, 1989·The American Psychologist·A Bandura
Sep 1, 1980·The American Journal of Psychiatry·J K Myers, M M Weissman
Apr 1, 1997·International Journal of Geriatric Psychiatry·R L Schein, H G Koenig
Jul 1, 1997·The Journal of Psychology·T Toray, E Cooley
Dec 16, 1997·Behavioral Medicine·J C BeckhamM J Costakis
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M DorvalB Mâsse
Oct 17, 1998·Journal of Psychosomatic Research·D J Newport, C B Nemeroff
Oct 25, 2000·British Journal of Cancer·D P Stark, A House
Feb 17, 2001·Psycho-oncology·J ZaboraS Piantadosi
Jan 5, 2002·Journal of the National Cancer Institute·Patricia A GanzThomas R Belin
Feb 9, 2002·BMJ : British Medical Journal·Ruth Little
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jesús M PrietoCristóbal Gastó
Apr 18, 2002·Journal of the National Cancer Institute·Sallie Anne NewellNina Johanna Savolainen
Apr 23, 2002·European Journal of Cancer Care·C KellyK Caldwell
Oct 29, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J K Kiecolt-GlaserR Glaser
Dec 5, 2002·Journal of the National Cancer Institute·Anne BrédartSylvie Dolbeault
May 21, 2003·Health and Quality of Life Outcomes·Linda E Carlson, Barry D Bultz
Jul 2, 2003·Psycho-oncology·Raymond C Nairn, Thomas V Merluzzi
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A GanzJulienne E Bower
Dec 10, 2003·Seminars in Oncology·Alice B Kornblith, Jennifer Ligibel
Feb 6, 2004·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Vicki S HelgesonHoward Seltman
May 20, 2004·Health and Quality of Life Outcomes·Deborah CassoStephen Taplin
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·Mary Jane Massie
Sep 24, 2004·Psycho-oncology·Vicki S Helgeson, Patricia L Tomich
Jan 25, 2005·Breast Cancer Research and Treatment·Quynh-Uyen T BuiJames S Goodwin
Feb 25, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·U R KleebergC Runge
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Oct 26, 2005·Cancer·Annette L StantonSharon R Sears
May 25, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Jennifer A LindeRobert W Jeffery
Aug 25, 2006·International Journal of Psychiatry in Medicine·Robyn L OsbornMichael Feuerstein
Nov 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C Earle
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Sep 27, 2007·Journal of the National Cancer Institute·Steve HickeyHilary Roberts
Dec 14, 2007·Journal of Psychosocial Oncology·Derek R HopkoChristine Mullane

❮ Previous
Next ❯

Citations

Dec 6, 2012·Journal of Behavioral Medicine·Kelly M CarpenterArdith Z Doorenbos
Aug 6, 2015·PeerJ·Andrea ChiricoThomas V Merluzzi
Oct 22, 2013·Palliative & Supportive Care·Geoffrey W CornerWilliam Breitbart
Dec 20, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Laura B DunnChristine Miaskowski
Jun 3, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryan D NippJennifer S Temel
Jun 14, 2017·Death Studies·Teresa P EdwardsDonald L Rosenstein
Mar 7, 2018·Psycho-oncology·Jing Min YuanXiu Qing Bu
Apr 24, 2018·Oncology Nursing Forum·Janie BrownAlannah Cooper
Dec 5, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lauren BolandDeirdre Connolly
Dec 3, 2016·Journal of Health Psychology·Trisha L Raque-BogdanBrooke Lamphere
Nov 23, 2018·Breast Cancer Research and Treatment·Roger J ZoorobRobert S Levine
Apr 23, 2019·European Journal of Cancer Care·Špela MiroševičZalika Klemenc Ketiš
May 9, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A FeldstainM R Chasen
Aug 2, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sharon L ManneCarolyn J Heckman
Jul 30, 2020·PloS One·Patricia MacíaIoseba Iraurgi
Jul 10, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Dawn Aubel
Dec 16, 2018·Journal of Behavioral Medicine·Raymond C Nairn, Thomas V Merluzzi
Sep 7, 2019·Health Psychology Open·Bethany ChapmanNazanin Derakshan
Apr 7, 2019·BMC Palliative Care·Samantha SerpentiniEleonora Capovilla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.